Skip to content
Home/Companies/Pharma/Pieffeuno

Pieffeuno

Pharma·Italy·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Pieffeuno?

Pieffeuno is an Italian Pharma company, currently owned by Primo Capital SGR since 2024.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Primo Capital SGR
Investor
Primo Capital SGR
Primo Climate · 2024 · VC

Key facts

HQItaly
SectorPharma
StatusActive

More from Primo Climate

Other portfolio companies in the same fund.

Rara Factory
Active
ClimateTechItaly· 2026
Blubrake
Active
MobilityItaly· 2025
DMAT
DMAT
Active
ClimateTechItaly· 2025
Krillmat
Active
ClimateTechItaly· 2025
Rarearth
Active
ClimateTechItaly· 2025
CheckmAb
Active
BiotechItaly· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Pieffeuno?

Pieffeuno is currently owned by Primo Capital SGR, through Primo Climate, since 2024.

When did Primo Capital SGR acquire Pieffeuno?

Primo Capital SGR acquired Pieffeuno in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue